Champions Oncology, Inc. $CSBR

What the company doesAI summary of filing

Champions Oncology is a revenue-generating research organization that provides technology solutions for drug discovery and development. The company operates three primary business lines: research services using its proprietary platforms to assist pharmaceutical and biotechnology companies with drug development studies; data licensing and a software-as-a-service offering called Lumin Bioinformatics that provides access to oncology datasets and computational analytics; and a nascent drug discovery and development business focused on targeted therapies, immune oncology, and cell therapy. The core of the company's platform is its proprietary bank of approximately 1,500 Patient Derived Xenograft (PDX) models deployed into advanced pharmacology and computational platforms, supported by a Datacenter containing approximately 3,500 molecular datasets and 3,000 clinical drug responses, for fiscal year 2026 revenues totaled approximately $59.4 million. [10-K 2026-07-27]

Segments: Research Services, Data Licenses, Software as a Service (Lumin Bioinformatics), Drug Discovery and Development